Efficacy of Cetirizine Hydrochloride Drops Combined with Fluticasone Propionate Inhalation in theTreatment of Allergic Rhinitis Complicated with Bronchial Asthma in Children

Huang Mengmeng; Dong Liangliang; Wang Hongmei

doi:10.13407/j.cnki.jpp.1672-108X.2024.02.008

您当前的位置：

首页 >

文章列表页 >

Efficacy of Cetirizine Hydrochloride Drops Combined with Fluticasone Propionate Inhalation in theTreatment of Allergic Rhinitis Complicated with Bronchial Asthma in Children

更新时间：2024-03-04

- Efficacy of Cetirizine Hydrochloride Drops Combined with Fluticasone Propionate Inhalation in theTreatment of Allergic Rhinitis Complicated with Bronchial Asthma in Children
- Vol. 30, Issue 2, Pages: 28-31(2024)
- 作者机构：
  
  聊城市第二人民医院,山东,聊城,252600
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2024.02.008
  CLC：
- Published：2024，
  
  Published Online：10 February 2024，
扫描看全文
Huang Mengmeng, Dong Liangliang, Wang Hongmei. Efficacy of Cetirizine Hydrochloride Drops Combined with Fluticasone Propionate Inhalation in theTreatment of Allergic Rhinitis Complicated with Bronchial Asthma in Children. [J]. 30(2):28-31(2024)
DOI：

Huang Mengmeng, Dong Liangliang, Wang Hongmei. Efficacy of Cetirizine Hydrochloride Drops Combined with Fluticasone Propionate Inhalation in theTreatment of Allergic Rhinitis Complicated with Bronchial Asthma in Children. [J]. 30(2):28-31(2024) DOI： 10.13407/j.cnki.jpp.1672-108X.2024.02.008.

摘要

目的:观察盐酸西替利嗪滴剂联合丙酸氟替卡松吸入气雾剂治疗过敏性鼻炎(AR)合并支气管哮喘(BA)患儿的疗效及安全性。方法:选取2020 年1 月-2022 年6 月我院收治的AR 合并BA 患儿84 例

按随机数表法分为联合组与对照组各42 例。对照组给予丙酸氟替卡松吸入气雾剂吸入治疗

联合组则采用盐酸西替利嗪滴剂联合丙酸氟替卡松吸入气雾剂治疗

比较两组患儿治疗前后AR 和BA 严重程度评分、肺功能指标[第1 秒用力呼气量(FEV1)、呼气流速(PEF)、用力肺活量(FVC)]、血清酶学[可溶性细胞间粘附分子-1(sICAM-1)、可溶性血管细胞间粘附分子-1(sVCAM-1)、白细胞介素-4(IL-4)、IL-10]、血清淀粉样蛋白(SAA)水平及不良反应发生情况。结果:治疗后

联合组AR 与BA 严重程度评分低于对照组

FEV1、PEF 及FVC 水平高于对照组(P 均<0. 05);两组sICAM-1、sVCAM-1、IL-4、IL-10 及SAA 水平均下降

且联合组均低于对照组( P 均<0. 05);两组患儿不良反应发生率比较差异无统计学意义(P>0. 05)。结论:采用盐酸西替利嗪滴剂联合丙酸氟替卡松吸入气雾剂治疗AR 合并 BA 患儿

能显著减轻临床症状

有效改善肺功能

调节血清酶学指标与SAA 水平

且不会增加不良反应的发生。

Abstract

Objective: To observe the efficacy and safety of cetirizine hydrochloride drops combined with fluticasone propionate inhalation in the treatment of allergic rhinitis (AR) complicated with bronchial asthma (BA) in children. Methods: A total of 84 children with AR complicated with BA admitted into our hospital from Jan. 2020 and Jun. 2022 were enrolled to be divided into the combination group and control group via the random number table method

with 42 cases in each group. The control group was treated with fluticasone propionate inhalation

while the combination group was additionally given cetirizine hydrochloride drops combined with fluticasone propionate inhalation. The scores of AR and BA severity

pulmonary function indicators such as forced expiratory volume in one second (FEV1)

peak expiratory flow (PEF)

forced vital capacity (FVC)

serum enzymes such as soluble intercellular adhesion molecule-1 (sICAM-1)

soluble vascular intercellular adhesion molecule-1 (sVCAM-1)

interleukin-4 (IL-4) and IL-10

serum amyloid protein A (SAA) before and after treatment and occurrence of adverse drug reactions were compared between two groups. Results: After treatment

scores of AR and BA severity in combination group were significantly lower than those in control group (P< 0. 05)

while levels of FEV1

PEF and FVC were significantly higher than those in control group (P<0. 05). After treatment

levels of sICAM-1

sVCAM-1

IL-4

IL-10 and SAA decreased in both groups

and the combination group was lower than control group (P< 0. 05). There was no significant difference in the incidence of adverse drug reactions between two groups (P >0. 05). Conclusion: Cetirizine hydrochloride drops combined with fluticasone propionate inhalation can significantly relieve clinical symptoms

effectively improve pulmonary function

regulate serum zymetology indicators and SAA in children with AR complicated with BA

which will not increase the incidence of adverse drug reactions.

关键词

盐酸西替利嗪滴剂丙酸氟替卡松过敏性鼻炎支气管哮喘血清酶学血清淀粉样蛋白

Keywords

cetirizine hydrochloride dropsfluticasone propionateallergic rhinitisbronchial asthmaserum enzymologyserumamyloid protein A

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Probioticson Inflammatory Factors and Oxidative Stress Markers in Children with Allergic Asthma

Current Status and Clinical Evaluation of Asthma Medication in Children: Based on Survey Results of 46 Medical Institutions

Clinical Significance of Detection of Nasal Nitric Oxide in Children with Allergic Rhinitis

Salbutamol and Ipratropium Bromide Combined with Magnesium Sulfate in the Treatment of Children with Acute Attack of Bronchial Asthma

Efficacy of Procaterol Combined with Montelukast in the Treatment of Bronchial Asthma in Children

Related Author

Wu Hongmei

Kong Xia

Li Yinfang

Hu Lihua

Yu Yuncui

Huang Huijie

Jia Lulu

Cao Wang

Related Institution

Nanjing Hospital Affiliated to Nanjing Medical University, the First Hospital of Nanjing

National Children’s Medical Center, Beijing Children’s Hospital, Capital Medical University

Shenzhen Children’s Hospital

The Second People’s Hospital of Hefei

Xiangyang No. 1 Prople’s Hospital, Affiliated Hospital of Hubei University of Medicine, Hubei Xiangyang

⁰